What is CAR-T Cell Therapy?

Lately, a company called Immuno Adoptive Cell Therapy, incubated at IIT Bombay has received approval from the Central Drugs Standard Control Organisation (CDSCO) for the first humanised CD-19 targeted Chimeric Antigen Receptor T Cell (CAR-T Cell) Therapy named NexCAR19 (Actalycabtagene autoleucel). It is a result of a decade-long collaborative effort between IIT Bombay and Tata … Read more